Jiang, Z., & Mao, Z. (2019). Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway. RSC advances, 9(61), 35473-35482. https://doi.org/10.1039/C9RA05933D
Chicago Style (17th ed.) CitationJiang, ZhongYu, and Zhen Mao. "Astragaloside IV (AS-IV) Alleviates the Malignant Biological Behavior of Hepatocellular Carcinoma via Wnt/β-catenin Signaling Pathway." RSC Advances 9, no. 61 (2019): 35473-35482. https://doi.org/10.1039/C9RA05933D.
MLA (9th ed.) CitationJiang, ZhongYu, and Zhen Mao. "Astragaloside IV (AS-IV) Alleviates the Malignant Biological Behavior of Hepatocellular Carcinoma via Wnt/β-catenin Signaling Pathway." RSC Advances, vol. 9, no. 61, 2019, pp. 35473-35482, https://doi.org/10.1039/C9RA05933D.